Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review
Molecular Pharmaceutics · 04.08.2025 · 22 (8) · 4474-4493
DOI: 10.1021/acs.molpharmaceut.5c00385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 11.07.2025. Verfasst von Ying Bai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: RNA, Messenger, Nanoparticles, Lipids, Gene Transfer Techniques. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 197 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) as gene delivery vectors have revolutionized the therapeutic paradigm in mRNA therapy. The pH-dependent lipid components can prevent endosomal retention of mRNA and promote the cytoplasmic translation of therapeutic proteins. However, current technologies still face two core challenges: the nonspecific liver accumulation rate of 30-90% after systemic administration, which is an organ targeting issue, and the inefficient cytoplasmic delivery with only 1-4% of nucleic acids escaping from endosomes. These problems severely limit their application in the treatment of extrahepatic diseases. This review systematically elaborates on the molecular composition and structure-function relationship of LNPs and explores the causes of their extrahepatic delivery obstacles. At the same time, we propose innovative strategies to enhance organ selectivity and endosomal escape efficiency. Additionally, through existing preclinical studies, key bottlenecks such as immune response control and quality control in large-scale production for the clinical translation of current technologies are revealed, providing a multidisciplinary theoretical framework for the development of the next generation of intelligent LNPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Clinical Research Center for Medical Imaging in Hubei Province, Wuhan 430022, China.
- Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China.
ORCID-Profile: Jing Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Bai, Y., Cui, L., Liu, T., Wang, Z., Cao, H., He, S., Qiu, J., Li, Y., Zhou, Y., Shi, J., & Wang, J. (2025). Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review. Molecular Pharmaceutics, 22(8), 4474-4493. https://doi.org/10.1021/acs.molpharmaceut.5c00385
Vancouver
Bai Y, Cui L, Liu T, Wang Z, Cao H, He S, et al. Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review. Molecular Pharmaceutics. 2025;22(8):4474-4493. doi:10.1021/acs.molpharmaceut.5c00385
BibTeX
@article{Bai2025,
author = {Bai, Ying and Cui, Li and Liu, Tianshu and Wang, Zhen and Cao, Haiyan and He, Shukun and Qiu, Jiani and Li, Yingxin and Zhou, Yilan and Shi, Jiawei and Wang, Jing},
title = {Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {8},
pages = {4474--4493},
doi = {10.1021/acs.molpharmaceut.5c00385}
}
EUVIMED